Pathogenesis of streptococcal and staphylococcal endocarditis

Infectious Disease Clinics of North America

Volumn 16, Issue 2, 2002, Pages 297-318

  Moreillon, Philippe ^a   Que, Yok A ^a   Bayer, Arnold S ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; GLUCAN; ADHESIN, STAPHYLOCOCCUS AUREUS; BACTERIAL PROTEIN; MEMBRANE ANTIGEN; THROMBOPLASTIN;

BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL GENOME; BLOOD CLOTTING; DISEASE COURSE; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; THROMBOCYTE; CLASSIFICATION; EXTRACELLULAR MATRIX; GROWTH, DEVELOPMENT AND AGING; HEART VALVE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; STAPHYLOCOCCUS; STREPTOCOCCUS;

ADHESINS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BLOOD PLATELETS; ENDOCARDITIS, BACTERIAL; EXTRACELLULAR MATRIX; HEART VALVES; HUMAN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOPLASTIN; HUMANS;

EID: 0035987602     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(01)00009-5     Document Type: Review

References (112)

1. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings
2. Infective endocarditis, 1984 through 1993: A clinical and microbiological survey
3. Epidemiologic aspects of infective endocarditis in an urban population. A 5-years prospective study
4. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: A prospective comparative study
5. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation
6. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions
7. Adherence of bacteria to heart valves in vitro
8. A human endothelial cell membrane protein that binds Staphylococcus aureus in vitro
9. Staphylococcus aureus proteins that bind to human endothelial cells
10. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells
11. Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes
12. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions
13. Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells
14. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study
15. The histopathology of endocardial sclerosis
16. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin
17. Adherence of glucan-positive and glucan-negative streptococcal strains to normal and damaged heart valves
18. Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease
19. MSCRAMM-mediated adherence of microorganisms to host tissues
20. Role of fibronectin in infective endocarditis
21. Sucrose-derived exopolysaccharides of Streptococcus mutans V403 contribute to infectivity in endocarditis
22. Infectivity of a glucan synthesis-defective mutant of Streptococcus gordonii (Challis) in a rat endocarditis model
23. The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis
24. Bacterial binding to extracellular matrix proteins - In vitro adhesion
25. Identification of a fibronectin binding protein from Streptococcus mutans
26. Cell wall-anchored CshA polypeptide (259 kilodaltons) in Streptococcus gordonii forms surface fibrils that confer hydrophobic and adhesive properties
27. Cell surface polypeptide CshA mediates binding of Streptococcus gordonii to other oral bacteria and to immobilized fibronectin
28. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis
29. Cell surface protein receptors in oral streptococci
30. Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats
31. Different mutations conferring penicillin-tolerance to streptococci result in distinct tolerance phenotypes and different treatment outcomes in rats with experimental endocarditis
32. Staphylococcus aureus infections
33. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope
34. Fibrinogen-binding protein/clumping factor from Staphylococcus aureus
35. Agr: A polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus
36. Cloning and sequencing of sar A of Staphylococcus aureus, a gene required for the expression of agr
37. The alternative sigma factor sigma B in Staphylococcus aureus: Regulation of the sig-B operon in response to growth phase and heat shock
38. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr
39. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis
40. Diminished virulence of a sargr-mutant of Staphylococcus aureus in the rabbit model of endocarditis
41. Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis
42. Role of the staphylococcal accessory gene regulator (sar) in septic arthritis
43. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence
44. Role of Staphylococcus aureus coagulase and clumping factor in the pathogenesis of experimental endocarditis
45. Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus
46. Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis
47. Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus
48. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent Streptococcus gordonii
49. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus
50. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus
51. Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector
52. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by gene expression in Lactococcus lactis
53. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus
54. A low-fibronectin-binding mutant of Staphylococcus aureus 879R4S has Tn918 inserted into its single fnb gene
55. Cell biology of tissue factor, the principal initiator of blood coagulation
56. Scanning electron microscopic observations of the surface of the initial lesion in experimental streptococcal endocarditis in the rabbit
57. The role of platelets in antimicrobial host defense
58. Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells
59. Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis
60. Role of monocytes in experimental Staphylococcus aureus endocarditis
61. Role of monocytes and bacteria in Staphylococcus epidermidis endocarditis
62. Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis
63. Role of phagocytosis in activation of the coagulation system in Streptococcus sanguis endocarditis
64. Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis
65. Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells
66. A comparative study of the aggregation of human, rat and rabbit platelets by members of the Streptococcus sanguis group
67. Platelet aggregation by oral streptococci
68. The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain
69. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis
70. An appraisal of the virulence factors associated with streptococcal endocarditis
71. Experimental endocarditis induction and platelet aggregation by Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius
72. Genetic loci of Streptococcus mitis that mediate binding to human platelets
73. Proteins PlbA and PlbB of Streptococcus mitis, which promote binding to human platelets, are encoded by a lysogenic prophage
74. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis
75. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains
76. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces
77. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis
78. Clumping factor A mediates binding of Staphylococcus aureus to human platelets
79. Purification and in vitro activities of rabbit platelet microbicidal proteins
80. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines
81. Effect of thrombocytopenia on the early course of streptococcal endocarditis
82. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis
83. Membrane permeabilization by thrombin-induced platelet microbicidal protein 1 is modulated by transmembrane voltage polarity and magnitude
84. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action
85. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity
86. In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis
87. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis
88. Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis
89. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source
90. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source
91. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action
92. Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis
93. Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis
94. Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis
95. Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis
96. Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis
97. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects
98. Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis
99. Virulence gene regulation by peptides in staphylococci and other Gram-positive bacteria
100. Is Staphylococcus aureus an intracellular pathogen?
101. Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model
102. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: A host defense role for platelet microbicidal proteins
103. Identification of novel staphylococcal virulence genes by in vivo expression technology
104. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis
105. Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen
106. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus
107. Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein
108. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin
109. Staphylococcus aureus expresses a major histocompatibility complex class II analog
110. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity
111. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus